[Skip to Navigation]
Article
August 19, 1988

Regression of Ocular Melanoma Metastatic to the Liver After Hepatic Arterial Chemoembolization With Cisplatin and Polyvinyl Sponge

Author Affiliations

From the Divisions of Medicine (Drs Mavligit, Patt, and Benjamin) and Diagnostic Imaging (Drs Charnsangavej, Carrasco, and Wallace), The University of Texas M. D. Anderson Cancer Center, Houston.

From the Divisions of Medicine (Drs Mavligit, Patt, and Benjamin) and Diagnostic Imaging (Drs Charnsangavej, Carrasco, and Wallace), The University of Texas M. D. Anderson Cancer Center, Houston.

JAMA. 1988;260(7):974-976. doi:10.1001/jama.1988.03410070102037
Abstract

Thirty patients with ocular melanoma metastatic to the liver were treated by hepatic arterial chemoembolization using an admixture of cisplatin and polyvinyl sponge. Tumor regression was complete in one patient and partial (>50%) in 13 patients. The total response rate was 46%. The median survival for the entire group was 11 months (95% confidence interval, nine to 18 months). Treatmentrelated morbidity was short-lived and included primarily severe upper right quadrant abdominal pain, transient paralytic ileus, and nonicteric hepatitis. Hepatic arterial chemoembolization provided effective palliation, with goodquality survival among 46% of patients with ocular melanoma metastatic to the liver.

(JAMA 1988;260:974-976)

×